CoChat

Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer

Open access
Datta, Jashodeep, Smith, J. Joshua, Chatila, Walid K., McAuliffe, John C., Kandoth, Cyriac, Vakiani, Efsevia, Frankel, Timothy L., Ganesh, Karuna, Wasserman, Isaac, Lipsyc-Sharf, Marla, Guillem, Jose, Nash, Garrett M., Paty, Philip B., Weiser, Martin R., Saltz, Leonard B., Berger, Michael F., Jarnagin, William R., Balachandran, Vinod, Kingham, T. Peter, Kemeny, Nancy E., Cercek, Andrea, Garcia-Aguilar, Julio, Taylor, Barry S., Viale, Agnes, Yaeger, Rona, Solit, David B., Schultz, Nikolaus, D'Angelica, Michael I. · 2020 · Clinical Cancer Research
Cited by 91

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Purpose: We aimed to investigate genomic correlates underlying extremes of survivorship in metastatic colorectal cancer and their applicability in informing survival in distinct subsets of patients with metastatic colorectal cancer. Experimental Design: We examined differences in oncogenic somatic alterations between metastatic colorectal cancer cohorts demonstrating extremes of survivorship following complete metastasectomy: ≤2-year (n = 17) and ≥10-year (n = 18) survivors. Relevant genomic findings, and their association with overall survival (OS), were validated in two independent datasets of 935 stage IV and 443 resected stage I–IV patients. Results: In the extremes-of-survivorship cohort, significant co-occurrence of KRAS hotspot mutations and TP53 alterations was observed in ≤2-year survivors (P < 0.001). When validating these findings in the independent cohort of 935 stage IV patients, incorporation of the cumulative effect of any oncogenic Ras/B-raf (i.e., either KRAS, NRAS, or BRAF) and TP53 alteration generated three prognostic clusters: (i) TP53-altered alone (median OS, 132 months); (ii) Ras/B-raf–altered alone (65 months) or Ras/B-raf- and TP53 pan-wild-type (60 months); and (iii) coaltered Ras/B-raf–TP53 (40 months; P < 0.0001). Coaltered Ras/B-raf–TP53 was independently associated with mortality (HR, 2.47; 95% confidence interval, 1.91–3.21; P < 0.001). This molecular profile predicted survival in the second independent cohort of 443 resected stage I–IV patients. Coaltered Ras/B-raf–TP53 was associated with worse OS in patients with liver (n = 490) and lung (n = 172) but not peritoneal surface (n = 149) metastases. Moreover, coaltered Ras/B-raf–TP53 tumors were significantly more likely to involve extrahepatic metastatic sites with limited salvage options. Conclusions: Genomic analysis of extremes of survivorship following colorectal cancer metastasectomy identifies a prognostic role for coaltered Ras/B-raf–TP53 and its association with distinct patterns of colorectal cancer metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-19-2390

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 91

Metadata

Authors
Datta, J., Smith, J. J., Chatila, W. K., McAuliffe, J. C., Kandoth, C., Vakiani, E., Frankel, T. L., Ganesh, K., Wasserman, I., Lipsyc-Sharf, M., Guillem, J., Nash, G. M., Paty, P. B., Weiser, M. R., Saltz, L. B., Berger, M. F., Jarnagin, W. R., Balachandran, V., Kingham, T. P., Kemeny, N. E., Cercek, A., Garcia-Aguilar, J., Taylor, B. S., Viale, A., Yaeger, R., Solit, D. B., Schultz, N., & D'Angelica, M. I.
Venue
Clinical Cancer Research
Published
2020-03-01
Volume
26
Issue
5
Pages
1077-1085
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2987342757
Cited by
91
References
9
FWCI
4.90
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-19-2390
The paper
Datta, J., Smith, J. J., Chatila, W. K., McAuliffe, J. C., Kandoth, C., Vakiani, E., Frankel, T. L., Ganesh, K., Wasserman, I., Lipsyc-Sharf, M., Guillem, J., Nash, G. M., Paty, P. B., Weiser, M. R., Saltz, L. B., Berger, M. F., Jarnagin, W. R., Balachandran, V., Kingham, T. P., . . . D'Angelica, M. I. (2020). Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-19-2390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.